Last reviewed · How we verify
Sanfu moxibustion — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Sanfu moxibustion (Sanfu moxibustion) — Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sanfu moxibustion TARGET | Sanfu moxibustion | Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sanfu moxibustion CI watch — RSS
- Sanfu moxibustion CI watch — Atom
- Sanfu moxibustion CI watch — JSON
- Sanfu moxibustion alone — RSS
Cite this brief
Drug Landscape (2026). Sanfu moxibustion — Competitive Intelligence Brief. https://druglandscape.com/ci/sanfu-moxibustion. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab